Co-Amlessa (perindopril tert-butylamine, indapamide, amlodipine) tablets 8 mg/2.5 mg/10 mg. #30

$38.68

Manufactured in: Poland

Co-Amlessa tablets are used to treat hypertension and reduce the risk of heart attack and stroke in patients with cardiovascular disease.

SKU: MED4148 Category:

Description

Co-Amlessa Tablets 8 mg/2.5 mg/10 mg.

Co-Amlessa tablets contain a combination of perindopril tert-butylamine, indapamide, and amlodipine. It is a medication used to treat high blood pressure (hypertension) and reduce the risk of heart attack and stroke in patients with cardiovascular disease.

Overview

Co-Amlessa is a fixed-dose combination medication that combines three different active ingredients to provide a synergistic effect in managing hypertension. Each tablet contains 8 mg. of perindopril tert-butylamine, 2.5 mg. of indapamide, and 10 mg. of amlodipine.

Perindopril Tert-Butylamine

Perindopril is an angiotensin-converting enzyme (ACE) inhibitor that works by blocking the action of ACE, an enzyme that causes blood vessels to constrict. By inhibiting ACE, perindopril helps relax blood vessels, reducing blood pressure and improving blood flow to the heart.

Indapamide

Indapamide is a thiazide-like diuretic that helps the kidneys remove excess salt and water from the body, reducing fluid retention and lowering blood pressure. It also helps to relax blood vessels, further contributing to the antihypertensive effects of Co-Amlessa.

Amlodipine

Amlodipine is a calcium channel blocker that works by relaxing blood vessels and improving blood flow. By blocking the entry of calcium into smooth muscle cells in the blood vessels, amlodipine helps dilate the vessels and reduce blood pressure.

Indications

Co-Amlessa tablets are indicated for the treatment of hypertension in patients who require combination therapy with perindopril, indapamide, and amlodipine. It is also used in patients with cardiovascular disease to reduce the risk of heart attack, stroke, and other cardiovascular events.

Dosage and Administration

The usual recommended dose of Co-Amlessa tablets is one tablet daily, preferably taken in the morning. The tablets should be swallowed whole with a glass of water and can be taken with or without food. It is important to follow the dosage instructions provided by your healthcare provider.

Contraindications

Co-Amlessa tablets are contraindicated in patients with a history of hypersensitivity to any of the components of the medication. It should not be used in patients with a known allergy to ACE inhibitors, thiazide diuretics, or calcium channel blockers.

Side Effects

Common side effects of Co-Amlessa may include dizziness, headache, fatigue, cough, nausea, and peripheral edema. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, contact your healthcare provider immediately.

Precautions

Before taking Co-Amlessa, inform your healthcare provider about any medical conditions you have, especially kidney or liver disease. It is important to monitor your blood pressure regularly while taking this medication and follow up with your healthcare provider as recommended.

Drug Interactions

Co-Amlessa may interact with other medications, including potassium-sparing diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and lithium. Inform your healthcare provider about all the medications you are taking to avoid potential drug interactions.

Storage

Co-Amlessa tablets should be stored at room temperature away from moisture and heat. Keep the medication in its original packaging and out of reach of children. Do not use the tablets if they are past the expiration date.

Conclusion

Co-Amlessa tablets are a combination medication that provides effective management of hypertension and reduces the risk of cardiovascular events in patients with cardiovascular disease. By combining perindopril, indapamide, and amlodipine, Co-Amlessa offers a comprehensive approach to blood pressure control and cardiovascular protection.